SLN - What's Going On With Silence Therapeutics Stock Today? | Benzinga
Silence Therapeutics Plc (NASDAQ:SLN) shares are trading lower in the morning session on Wednesday.
The company reported a loss per share of (38.9) pence for 2023, narrower than the (41.9) pence loss per share a year ago. Collaboration revenues were £25.4 million versus £17.501 million a year ago.
Net loss was £(43.3) million for 2023, compared to a net loss of £(40.5) million in 2022.
“We ended December 2023 with approximately $68.8 million and significantly increased our cash position in early 2024 to over $200 million,” ...